Roseomonas species infections in humans: a systematic review

References

• Rihs JD, Brenner DJ, Weaver RE, Steigerwalt AG, Hollis DG, Yu VL. Roseomonas, a new genus associated with bacteremia and other human infections. J Clin Microbiol. 1993;31(12):3275–83.
   PubMed Web of Science ®Google Scholar
• Romano-Bertrand S, Bourdier A, Aujoulat F, Michon A-L, Masnou A, Parer S, Marchandin H, Jumas-Bilak E. Skin microbiota is the main reservoir of Roseomonas mucosa, an emerging opportunistic pathogen so far assumed to be environmental. Clin Microbiol Infect. 2016;22(8):737.e1–737.e7.
   Web of Science ®Google Scholar
• Zhang Y-Q, Yu L-Y, Wang D, Liu H-Y, Sun C-H, Jiang W, Zhang Y-Q, Li W-J. Roseomonas vinacea sp. nov., a Gram-negative coccobacillus isolated from a soil sample. Int J Syst Evol Microbiol. 2008;58(Pt 9):2070–4.
   PubMedGoogle Scholar
• Gallego V, Sánchez-Porro C, García MT, Ventosa A. Roseomonas aquatica sp. nov., isolated from drinking water. Int J Syst Evol Microbiol. 2006;56(Pt 10):2291–5.
   PubMedGoogle Scholar
• Chung EJ, Yoon HS, Kim KH, Jeon CO, Chung YR. Roseomonas oryzicola sp. nov., isolated from the rhizosphere of rice (Oryza sativa L.). Int J Syst Evol Microbiol. 2015;65(12):4839–44.
   PubMedGoogle Scholar
• Dé I, Rolston KV, Han XY. Clinical significance of Roseomonas species isolated from catheter and blood samples: analysis of 36 cases in patients with cancer. Clin Infect Dis. 2004;38(11):1579–84.
   PubMed Web of Science ®Google Scholar
• Wang C-M, Lai C-C, Tan C-K, Huang Y-C, Chung K-P, Lee M-R, Hwang K-P, Hsueh P-R. Clinical characteristics of infections caused by Roseomonas species and antimicrobial susceptibilities of the isolates. Diagn Microbiol Infect Dis. 2012;72(3):199–203.
   PubMed Web of Science ®Google Scholar
• Nahass RG1, Wisneski R, Herman DJ, Hirsh E, Goldblatt K. Vertebral osteomyelitis due to Roseomonas species: case report and review of the evaluation of vertebral osteomyelitis. Clin Infect Dis. 1995;21(6):1474–6.
   PubMed Web of Science ®Google Scholar
• Malini S, Goh BL, Lim TS. A rare case of Roseomonas gilardii peritonitis in a patient on continuous ambulatory peritoneal dialysis. Perit Dial Int. 2016;36(5):578
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–9.
   PubMed Web of Science ®Google Scholar
• Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008–12.
   PubMed Web of Science ®Google Scholar
• Wallace BC, Small K, Brodley CE, Lau J, Trikalinos TA. Deploying an interactive machine learning system in an evidence-based practice center: abstrackr. Proceedings of the ACM International Health Informatics IHI. 2012. p. 819–824.
   Google Scholar
• Michon AL, Saumet L, Bourdier A, Haouy S, Sirvent N, Marchandin H. Bacteremia due to imipenem-resistant Roseomonas mucosa in a child with acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2014;36:e165–e168.
   PubMed Web of Science ®Google Scholar
• Tabin G, Danenhower C, Reardon D, Dimmig J, McCormick G. Opportunistic Roseomonas keratitis. Cornea. 2001;20(7):772–3.
   PubMed Web of Science ®Google Scholar
• Srifuengfung S, Tharavichitkul P, Pumprueg S, Tribuddharat C. Roseomonas gilardii subsp rosea, a pink bacterium associated with bacteremia: the first case in Thailand. Southeast Asian J Trop Med Public Health. 2007;38(5):886–91.
   PubMedGoogle Scholar
• Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schünemann HJ, GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924–6.
   PubMed Web of Science ®Google Scholar
• Shao S, Guo X, Guo P, Cui Y, Chen Y. Roseomonas mucosa infective endocarditis in patient with systemic lupus erythematosus: case report and review of literature. BMC Infect Dis. 2019;19(1):140.
   PubMed Web of Science ®Google Scholar
• Richardson JD. Failure to clear a Roseomonas line infection with antibiotic therapy. Clin Infect Dis. 1997;25(1):155.
   PubMed Web of Science ®Google Scholar
• Lewis L, Stock F, Williams D, Weir S, Gill VJ. Infections with Roseomonas gilardii and review of characteristics used for biochemical identification and molecular typing. Am J Clin Pathol. 1997;108(2):210–6.
   PubMed Web of Science ®Google Scholar
• Alcalá L, Vasallo FJ, Cercenado E, García-Garrote F, Rodríguez-Créixems M, Bouza E. Catheter-related bacteremia due to Roseomonas gilardii sp. nov. J Clin Microbiol. 1997;35(10):2712.
   PubMed Web of Science ®Google Scholar
• Kimura K, Hagiya H, Nishi I, Yoshida H, Tomono K. Roseomonas mucosa bacteremia in a neutropenic child: A case report and literature review. IDCases. 2018;14:e00469.
   PubMed Web of Science ®Google Scholar
• Subudhi CP, Adedeji A, Kaufmann ME, Lucas GS, Kerr JR. Fatal Roseomonas gilardii bacteremia in a patient with refractory blast crisis of chronic myeloid leukemia. Clin Microbiol Infect. 2001;7(10):573–5.
   PubMed Web of Science ®Google Scholar
• Marin ME, del Pont J, Dibar E, Caniggia LF, Greco G, Flores Y, Ascione A. Catheter-related bacteremia caused by Roseomonas gilardii in an immunocompromised patient. Int J Infect Dis. 2001;5(3):170–1.
   PubMedGoogle Scholar
• Christakis GB, Perlorentzou S, Alexaki P, Megalakaki A, Zarkadis IK. Central line-related bacteraemia due to Roseomonas mucosa in a neutropenic patient with acute myeloid leukaemia in Piraeus, Greece. J Med Microbiol. 2006;55(Pt 8):1153–6.
   PubMed Web of Science ®Google Scholar
• Kim YK, Moon JS, Song KE, Lee WK. Two cases of bacteremia due to Roseomonas mucosa. Ann Lab Med. 2016;36(4):367–70.
   PubMed Web of Science ®Google Scholar
• Al-Anazi KA, AlHashmi H, Abdalhamid B, AlSelwi W, AlSayegh M, Alzayed A, Alshibani Z, AlGarni A, Al-Ghanem A, Hassan H, et al. Roseomonas bacteremia in a recipient of an allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis. 2013;15(4):E144–147.
   PubMed Web of Science ®Google Scholar
• Bard JD, Deville JG, Summanen PH, Lewinski MA. Roseomonas mucosa isolated from bloodstream of pediatric patient. J Clin Microbiol. 2010;48(8):3027–9.
   PubMed Web of Science ®Google Scholar
• McLean TW, Rouster-Stevens K, Woods CR, Shetty AK. Catheter-related bacteremia due to Roseomonas species in pediatric hematology/oncology patients. Pediatr Blood Cancer. 2006;46(4):514–6.
   PubMed Web of Science ®Google Scholar
• Elshibly S, Xu J, McClurg RB, Rooney PJ, Millar BC, Alexander HD, Kettle P, Moore JE. Central line-related bacteremia due to Roseomonas mucosa in a patient with diffuse large B-cell non-Hodgkin's lymphoma. Leuk Lymphoma. 2005;46(4):611–4.
   PubMed Web of Science ®Google Scholar
• Shokar NK, Shokar GS, Islam J, Cass AR. Roseomonas gilardii infection: case report and review. J Clin Microbiol. 2002;40(12):4789–91.
   PubMed Web of Science ®Google Scholar
• Struthers M, Wong J, Janda JM. An initial appraisal of the clinical significance of Roseomonas species associated with human infections. Clin Infect Dis. 1996;23(4):729–33.
   PubMed Web of Science ®Google Scholar
• Fanella S, Schantz D, Karlowsky J, Rubinstein E. Septic arthritis due to Roseomonas gilardii in an immunocompetent adolescent. J Med Microbiol. 2009;58(Pt 11):1514–6.
   PubMed Web of Science ®Google Scholar
• Sipsas NV, Papaparaskevas J, Stefanou I, Kalatzis K, Vlachoyiannopoulos P, Avlamis A. Septic arthritis due to Roseomonas mucosa in a rheumatoid arthritis patient receiving infliximab therapy. Diagn Microbiol Infect Dis. 2006;55(4):343–5.
   PubMed Web of Science ®Google Scholar
• Kim K-Y, Hur J, Jo W, Hong J, Cho O-H, Kang DH, Kim S, Bae I-G. Infectious spondylitis with bacteremia caused by Roseomonas mucosa in an immunocompetent patient. Infect Chemother. 2015;47(3):194–6.
   PubMed Web of Science ®Google Scholar
• Koutserimpas C, Samonis G, Plataki MN, Bikis C, Kontakis G, Kofteridis DP. Multidrug-resistant Gram-negative osteomyelitis: a 10-year study. G Chir. 2018;34(5):284–90.
   PubMedGoogle Scholar
• Maraki S, Bantouna V, Lianoudakis E, Stavrakakis I, Scoulica E. Roseomonas spinal epidural abscess complicating instrumented posterior lumbar interbody fusion. J Clin Microbiol. 2013;51(7):2458–60.
   PubMed Web of Science ®Google Scholar
• Ece G, Ruksen M, Akay A. Case report: cranioplasty infection due to Roseomonas gilardii at a university hospital in Turkey. Pan Afr Med J. 2013;14:162.
   PubMedGoogle Scholar
• Matsukuma Y, Sugawara K, Shimano S, Yamada S, Tsuruya K, Kitazono T, Higashi H. A case of bacterial peritonitis caused by Roseomonas mucosa in a patient undergoing continuous ambulatory peritoneal dialysis. CEN Case Rep. 2014;3(2):127–31.
   PubMedGoogle Scholar
• Tsai SF, Chen CH, Shu KH, Wu MJ. Peritonitis caused by Roseomonas in a patient undergoing automated peritoneal dialysis: case report and literature review. Intern Med. 2012;51(13):1721–4.
   PubMed Web of Science ®Google Scholar
• Boyd MA, Laurens MB, Fiorella PD, Mendley SR. Peritonitis and technique failure caused by Roseomonas mucosa in an adolescent infected with HIV on continuous cycling peritoneal dialysis. J Clin Microbiol. 2012;50(11):3801–4.
   PubMed Web of Science ®Google Scholar
• Sandoe JA, Malnick H, Loudon KW. A case of peritonitis caused by Roseomonas gilardii in a patient undergoing continuous ambulatory peritoneal dialysis. J Clin Microbiol. 1997;35(8):2150–2.
   PubMed Web of Science ®Google Scholar
• Bibashi E, Sofianou D, Kontopoulou K, Mitsopoulos E, Kokolina E. Peritonitis due to Roseomonas fauriae in a patient undergoing continuous ambulatory peritoneal dialysis. J Clin Microbiol. 2000;38:456–7.
   PubMed Web of Science ®Google Scholar
• Chen KJ, Lai CC, Kuo YH, Wu WC, Chen TL. Chronic postoperative Roseomonas endophthalmitis. J Clin Microbiol. 2009;47(1):266–7.
   PubMed Web of Science ®Google Scholar
• Bhende M, Karpe A, Arunachalam S, Therese KL, Biswas J. Endogenous endophthalmitis due to Roseomonas mucosa presenting as a subretinal abscess. J Ophthalmic Inflamm Infect. 2017;7(1):5.
   PubMedGoogle Scholar
• Goyal S, Warner DB. Roseomonas keratitis after remote penetrating keratoplasty. Graefes Arch Clin Exp Ophthalmol. 2013;251(3):1025–7.
   PubMed Web of Science ®Google Scholar
• Kaore NM, Khan Z, Aher AR, Ramnani VK. Community acquired Roseomonas infection in a pre-existing Tubercular lung lesion. Lung India. 2014;31(3):289–92.
   PubMedGoogle Scholar
• Nolan JS, Waites KB. Nosocomial ventriculitis due to Roseomonas gilardii complicating subarachnoid haemorrhage. J Infect. 2005;50(3):244–51.
   PubMed Web of Science ®Google Scholar
• Singal A, Malani PN, Day LJ, Pagani FD, Clark NM. Roseomonas infection associated with a left ventricular assist device. Infect Control Hosp Epidemiol. 2003;24(12):963–5.
   PubMed Web of Science ®Google Scholar
• Aminzadeh Z, Simpson P, Athan E. Central venous catheter associated blood stream infections (CVC-BSIs) in the non-intensive care settings: Epidemiology, microbiology and outcomes. Infect Dis Health. 2019;24(4):222–8.
   PubMed Web of Science ®Google Scholar
• Herc E, Patel P, Washer LL, Conlon A, Flanders SA, Chopra V. A model to predict central-line-associated bloodstream infection among patients with peripherally inserted central catheters: The MPC score. Infect Control Hosp Epidemiol. 2017;38(10):1155–66.
   PubMed Web of Science ®Google Scholar
• Kolinsky DC, Liang SY. Musculoskeletal infections in the emergency department. Emerg Med Clin North Am. 2018;36(4):751–66.
   PubMed Web of Science ®Google Scholar
• Mehrotra R, Devuyst O, Davies SJ, Johnson DW. The current state of peritoneal dialysis. J Am Soc Nephrol. 2016;27(11):3238–52.
   PubMed Web of Science ®Google Scholar
• Ghali JR, Bannister KM, Brown FG, Rosman JB, Wiggins KJ, Johnson DW, McDonald SP. Microbiology and outcomes of peritonitis in Australian peritoneal dialysis patients. Perit Dial Int. 2011;31(6):651–62.
   PubMed Web of Science ®Google Scholar
• Jarvis EM, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, Bannister KM, Johnson DW. Predictors, treatment, and outcomes of non-pseudomonas Gram-negative peritonitis. Kidney Int. 2010;78(4):408–14.
   PubMed Web of Science ®Google Scholar
• Rudolph WW, Gunzer F, Trauth M, Bunk B, Bigge R, Schröttner P. Comparison of VITEK 2, MALDI-TOF MS, 16S rRNA gene sequencing, and whole-genome sequencing for identification of Roseomonas mucosa. Microb Pathog. 2019;134:103576.
   PubMed Web of Science ®Google Scholar
• Han XY, Pham AS, Tarrand JJ, Rolston KV, Helsel LO, Levett PN. Bacteriologic characterization of 36 strains of Roseomonas species and proposal of Roseomonas mucosa sp nov and Roseomonas gilardii subsp rosea subsp nov. Am J Clin Pathol. 2003;120(2):256–64.
   PubMed Web of Science ®Google Scholar
• Diesendorf N, Köhler S, Geißdörfer W, Grobecker-Karl T, Karl M, Burkovski A. Characterisation of Roseomonas mucosa isolated from the root canal of an infected tooth. BMC Res Notes. 2017;10(1):212.
   PubMedGoogle Scholar
• Lee YM, Moon C, Kim YJ, Lee HJ, Lee MS, Park KH. Clinical impact of delayed catheter removal for patients with central-venous-catheter-related Gram-negative bacteraemia. J Hosp Infect. 2018;99(1):106–13.
   PubMed Web of Science ®Google Scholar
• Nielsen SL. The incidence and prognosis of patients with bacteremia. Dan Med J. 2015;62:B5128.
   PubMed Web of Science ®Google Scholar
• Fitzpatrick JM, Biswas JS, Edgeworth JD, Islam J, Jenkins N, Judge R, Lavery AJ, Melzer M, Morris-Jones S, Nsutebu EF, et al. Gram-negative bacteraemia; a multi-centre prospective evaluation of empiric antibiotic therapy and outcome in English acute hospitals. Clin Microbiol Infect. 2016;22(3):244–51.
   PubMed Web of Science ®Google Scholar
• Maneiro JR, Souto A, Cervantes EC, Mera A, Carmona L, Gomez-Reino JJ. Predictors of treatment failure and mortality in native septic arthritis. Clin Rheumatol. 2015;34(11):1961–7.
   PubMed Web of Science ®Google Scholar
• Courjon J, Lemaignen A, Ghout I, Therby A, Belmatoug N, Dinh A, Gras G, Bernard L. Pyogenic vertebral osteomyelitis of the elderly: Characteristics and outcomes. PLoS One. 2017;12(12):e0188470.
   PubMed Web of Science ®Google Scholar
• Chang W-S, Ho M-W, Lin P-C, Ho C-M, Chou C-H, Lu M-C, Chen Y-J, Chen H-T, Wang J-H, Chi C-Y, et al. Clinical characteristics, treatments, and outcomes of hematogenous pyogenic vertebral osteomyelitis, 12-year experience from a tertiary hospital in central Taiwan. J Microbiol Immunol Infect. 2018;51(2):235–42.
   PubMedGoogle Scholar
• Ioannou P, Tsagkaraki E, Athanasaki A, Tsioutis C, Gikas A. Gram-negative bacteria as emerging pathogens affecting mortality in skin and soft tissue infections. Hippokratia. 2018;22(1):23–8.
   PubMed Web of Science ®Google Scholar
• Roghmann MC, Warner J, Mackowiak PA. The relationship between age and fever magnitude. Am J Med Sci. 2001;322(2):68–70.
   PubMed Web of Science ®Google Scholar
• Lu SH, Chen YC, Chang YC, Yen CJ, Dai YT. Effect of age on febrile response in patients with healthcare-associated bloodstream infection. Geriatr Nurs. 2013;34(5):366–72.
   PubMed Web of Science ®Google Scholar
• Sundén-Cullberg J, Rylance R, Svefors J, Norrby-Teglund A, Björk J, Inghammar M. Fever in the emergency department predicts survival of patients with severe sepsis and septic shock admitted to the ICU. Crit Care Med. 2017;45:591–9.
   PubMed Web of Science ®Google Scholar
• Starr ME, Saito H. Sepsis in old age: review of human and animal studies. Aging Dis. 2014;5(2):126–36.
   PubMed Web of Science ®Google Scholar